107 related articles for article (PubMed ID: 24616267)
21. Structural insights into catalysis by βC-S lyase from Streptococcus anginosus.
Kezuka Y; Yoshida Y; Nonaka T
Proteins; 2012 Oct; 80(10):2447-58. PubMed ID: 22674431
[TBL] [Abstract][Full Text] [Related]
22. Novel mechanism for conditional aerobic growth of the anaerobic bacterium Treponema denticola.
Lai Y; Chu L
Appl Environ Microbiol; 2008 Jan; 74(1):73-9. PubMed ID: 17981934
[TBL] [Abstract][Full Text] [Related]
23. [NMR screening of potential inhibitors of Citrobacter freundii methionine].
Batuev EA; Lizunov AIu; Morozova EA; Klochkov VV; Anufrieva NV; Demidkina TV; Pol'shakov VI
Mol Biol (Mosk); 2014; 48(6):1019-29. PubMed ID: 25845243
[TBL] [Abstract][Full Text] [Related]
24. Role of Aggregatibacter actinomycetemcomitans in glutathione catabolism.
Chu L; Xu X; Su J; Song L; Lai Y; Dong Z; Cappelli D
Oral Microbiol Immunol; 2009 Jun; 24(3):236-42. PubMed ID: 19416454
[TBL] [Abstract][Full Text] [Related]
25. Molecular docking analysis of thiazo inhibitors with the virulent factor cystalysin from
Andrew S; Sankaran K; Sekaran S; Rengasamy G; Veeraraghavan VP; Eswaramoorthy R
Bioinformation; 2023; 19(1):94-98. PubMed ID: 37720279
[No Abstract] [Full Text] [Related]
26. Site-directed mutagenesis provides insight into racemization and transamination of alanine catalyzed by Treponema denticola cystalysin.
Cellini B; Bertoldi M; Paiardini A; D'Aguanno S; Voltattorni CB
J Biol Chem; 2004 Aug; 279(35):36898-905. PubMed ID: 15210695
[TBL] [Abstract][Full Text] [Related]
27. Treponema denticola invasion into human gingival epithelial cells.
Inagaki S; Kimizuka R; Kokubu E; Saito A; Ishihara K
Microb Pathog; 2016 May; 94():104-11. PubMed ID: 26806000
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
Lv PC; Wang KR; Yang Y; Mao WJ; Chen J; Xiong J; Zhu HL
Bioorg Med Chem Lett; 2009 Dec; 19(23):6750-4. PubMed ID: 19836235
[TBL] [Abstract][Full Text] [Related]
29. Discovery of Small-Molecule Antibiotics against a Unique tRNA-Mediated Regulation of Transcription in Gram-Positive Bacteria.
Frohlich KM; Weintraub SF; Bell JT; Todd GC; Väre VYP; Schneider R; Kloos ZA; Tabe ES; Cantara WA; Stark CJ; Onwuanaibe UJ; Duffy BC; Basanta-Sanchez M; Kitchen DB; McDonough KA; Agris PF
ChemMedChem; 2019 Apr; 14(7):758-769. PubMed ID: 30707489
[TBL] [Abstract][Full Text] [Related]
30. L-cysteine desulfidase: an [4Fe-4S] enzyme isolated from Methanocaldococcus jannaschii that catalyzes the breakdown of L-cysteine into pyruvate, ammonia, and sulfide.
Tchong SI; Xu H; White RH
Biochemistry; 2005 Feb; 44(5):1659-70. PubMed ID: 15683250
[TBL] [Abstract][Full Text] [Related]
31. High production of methyl mercaptan by L-methionine-alpha-deamino-gamma-mercaptomethane lyase from Treponema denticola.
Fukamachi H; Nakano Y; Okano S; Shibata Y; Abiko Y; Yamashita Y
Biochem Biophys Res Commun; 2005 May; 331(1):127-31. PubMed ID: 15845368
[TBL] [Abstract][Full Text] [Related]
32. Structure-based screening of inhibitors against KPC-2: designing potential drug candidates against multidrug-resistant bacteria.
Danishuddin M; Khan A; Faheem M; Kalaiarasan P; Hassan Baig M; Subbarao N; Khan AU
J Biomol Struct Dyn; 2014; 32(5):741-50. PubMed ID: 23600675
[TBL] [Abstract][Full Text] [Related]
33. Novel small molecule inhibitors targeting the "switch region" of bacterial RNAP: structure-based optimization of a virtual screening hit.
Sahner JH; Groh M; Negri M; Haupenthal J; Hartmann RW
Eur J Med Chem; 2013 Jul; 65():223-31. PubMed ID: 23711833
[TBL] [Abstract][Full Text] [Related]
34. Structure and Mechanism of Ergothionase from Treponema denticola.
Maurer A; Leisinger F; Lim D; Seebeck FP
Chemistry; 2019 Aug; 25(44):10298-10303. PubMed ID: 31188501
[TBL] [Abstract][Full Text] [Related]
35. Co-expression of Arabidopsis thaliana phytochelatin synthase and Treponema denticola cysteine desulfhydrase for enhanced arsenic accumulation.
Tsai SL; Singh S; Dasilva NA; Chen W
Biotechnol Bioeng; 2012 Feb; 109(2):605-8. PubMed ID: 21915851
[TBL] [Abstract][Full Text] [Related]
36. In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.
Romani AA; Baroni MC; Taddei S; Ghidini F; Sansoni P; Cavirani S; Cabassi CS
J Pept Sci; 2013 Sep; 19(9):554-65. PubMed ID: 23893489
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, molecular docking and biological evaluation of metronidazole derivatives containing piperazine skeleton as potential antibacterial agents.
Wang SF; Yin Y; Qiao F; Wu X; Sha S; Zhang L; Zhu HL
Bioorg Med Chem; 2014 Apr; 22(8):2409-15. PubMed ID: 24680059
[TBL] [Abstract][Full Text] [Related]
38. Novel Schiff-base-derived FabH inhibitors with dioxygenated rings as antibiotic agents.
Zhou Y; Du QR; Sun J; Li JR; Fang F; Li DD; Qian Y; Gong HB; Zhao J; Zhu HL
ChemMedChem; 2013 Mar; 8(3):433-41. PubMed ID: 23401291
[TBL] [Abstract][Full Text] [Related]
39. Molecular modeling and simulation of FabG, an enzyme involved in the fatty acid pathway of Streptococcus pyogenes.
Shafreen RB; Pandian SK
J Mol Graph Model; 2013 Sep; 45():1-12. PubMed ID: 23988477
[TBL] [Abstract][Full Text] [Related]
40. Identification of novel antimycobacterial chemical agents through the in silico multi-conformational structure-based drug screening of a large-scale chemical library.
Koseki Y; Kinjo T; Kobayashi M; Aoki S
Eur J Med Chem; 2013 Feb; 60():333-9. PubMed ID: 23314046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
